Industry Reports

Grifols will donate a minimum of 140 million international units (IU) of blood clotting factor medicines (Factor VIII) to the World Federation of Hemophilia (WFH) Humanitarian Aid…
Read More...

Novartis announced that it has it has it has exercised an option to in-license ECF843 for ophthalmic indication worldwide to strengthen R&D pipeline. The closing of the deal is…
Read More...

Digital diabetes management platform GlucoMe announced the appointment of John Erickson as EVP, General Manager North America. In this role, John will be responsible for leading the…
Read More...

Aimmune Therapeutics, Inc. announced the appointment of Eric Bjerkholt as Chief Financial Officer. Mr. Bjerkholt joins Aimmune from Sunesis Pharmaceuticals, Inc., where, over 13…
Read More...

Lyndra, Inc. announced the closing of a $23 Million Series A financing, led by Polaris Partners, with participation from Quark Venture and GF Securities, Yonghua Capital, Healthlink…
Read More...

Icon Bioscience Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome drug-delivery platform to develop unique intraocular eye-care therapeutics announced…
Read More...

BMS (Bristol-Myers Squibb) announced that it has entered into two separate agreements with Biogen and Roche to license to compounds. BMS-986168, an anti-eTau compound in development…
Read More...

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in…
Read More...

Sharp Packaging Services (“Sharp”), a division of UDG Healthcare, plc, a global leader in contract packaging and clinical supply services, today announced that it has acquired a…
Read More...

Sharp Clinical Services (Sharp), part of UDG Healthcare plc has announced a £9 million  investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution…
Read More...

Astellas Pharma Inc. and Ogeda SA announced that Astellas and Ogeda shareholders have entered into a definitive agreement under which Astellas has agreed to acquire Ogeda a privately…
Read More...

Espero Pharmaceuticals, Inc., a privately held, commercial-stage cardiovascular pharmaceutical company, and Armetheon, Inc., a privately held, late-clinical stage pharmaceutical company…
Read More...

Clinical-stage immuno-oncology firm Agenus is reorganizing its business and operations to straighten its focus on clinical development of its two checkpoint inhibitor antibodies and…
Read More...

Vanda Pharmaceuticals Inc. announced that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will acquire an exclusive worldwide license from UCSF…
Read More...

Vanda Pharmaceuticals Inc. announced that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will acquire an exclusive worldwide license from UCSF…
Read More...

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products announced that it has completed the divestiture of its rights to the royalty stream from global…
Read More...

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products, today announced it has completed the divestiture of its rights to the royalty stream from…
Read More...

BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it has acquired Agalimmune Ltd., a private UK-based company with an…
Read More...

Mallinckrodt plc, a leading specialty pharmaceutical company, announced today it has closed the sale of its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in…
Read More...

Bristol-Myers Squibb Company and CytomX Therapeutics, Inc., a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer, today announced an…
Read More...